总部位于伦敦的生物技术初创公司Baseimmune宣布，其在A轮融资中成功筹集了1130万美元（900万英镑）。这笔资金将用于加速其尖端的机器学习平台的发展，该平台旨在简化疫苗的设计过程。此次超额认购的投资者包括MSD Global Health Innovation Fund、IQ Capital以及Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc等早期支持者。Baseimmune的平台利用人工智能技术，大幅缩短了疫苗的研发周期，提高了设计的精准性和效率。随着全球对快速有效的疫苗开发需求的不断增长，Baseimmune的这一创新技术有望在未来的公共卫生危机中发挥关键作用。
英文标题：Baseimmune raises $11.3 million in A-round funding to advance AI-powered vaccine design platform
英文关键词：AI vaccine design, startup, funding
英文新闻内容：
London-based biotechnology startup Baseimmune has announced that it has raised $11.3 million (£9 million) in an A-round funding. The funds will be used to accelerate the development of its cutting-edge machine learning platform aimed at streamlining the vaccine design process. The oversubscribed investment round includes MSD Global Health Innovation Fund, IQ Capital, and early backers such as Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc. Baseimmune’s platform leverages AI to significantly reduce the vaccine development cycle, enhancing design precision and efficiency. As global demand for rapid and effective vaccine development continues to grow, Baseimmune’s innovative technology is expected to play a crucial role in future public health crises.
【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/
Views: 1